The effects of melittin at increasing concentrations on: [H-3]GABA rel
ease from mouse brain synaptosomes; on the radioactivity released from
[H-3]arachidonic acid labelled synaptosomal membranes; on synaptosome
s ultrastructure and on the leakage of the cytoplasmic marker, lactate
-dehydrogenase (LDH) was investigated. Melittin 0.3, 1, 3, 7, and 10 m
u M progressively increases [H-3]GABA release, but the efficacy of mel
ittin is decreased when the amount of tissue exposed to a constant con
centration of the toxin increases. The release of [H-3]GABA induced by
melittin below 3 mu M is Ca2+ dependent, but not that induced by the
higher concentrations. The Ca2+ dependent fraction of the [H-3]GABA re
leased by 0.3 mu M melittin is selectively inhibited by 10 mu M quinac
rine and 1 mu M nordihydroguaiaretic acid (NDGA) and facilitated by 3
mu M indomethacin, whereas the Ca2+ independent fraction of the [H-3]G
ABA released by melittin is not. Ln the presence of Ca2+, melittin 0.3
, 1 and 10 mu M progressively increases [H-3]arachidonic acid release
over control release, but the effectiveness of melittin is also decrea
sed as the amount of tissue increases. No apparent changes in synaptos
omes ultrastructure are observed in 0.3 mu M treated synaptosomes, but
a noticeable disorganization is produced in 10 mu M melittin-treated
synaptosomes, independently on the presence of external Ca2+. LDH acti
vity only increases over control activity in the supernatant solutions
of 10 mu M melittin treated synaptosomes, also in a Ca2+ independent
manner. Our interpretation of these results is that the Ca2+-dependent
, pharmacologic sensitive component of melittin-induced release of [H-
3]GABA, unmasked when 0.3 mu M melittin was used, involves the activat
ion of a Ca2+-dependent type of membrane PLA(2). The Ca2+-independent
release of [3H]GABA is in contrast, highly probable to be due to the m
embrane perturbation produced by complex melittin/lipid interactions.